Anton Gueth

Insider Reports History

Entity
Individual
Signature
/s/ Lisa M. Kallebo as attorney-in-fact for Anton Gueth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anton Gueth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ANTARES PHARMA, INC. Director Common Stock 0 $5.60 May 24, 2022 By Spouse, Pamela Harrington
ANTARES PHARMA, INC. Director Common Stock 0 $5.60 May 24, 2022 Direct
ANTARES PHARMA, INC. Director Stock Option (right to buy) 0 May 24, 2022 Direct

Insider Reports Filed by Anton Gueth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATRS ANTARES PHARMA, INC. May 24, 2022 11 -$2.62M 4 May 26, 2022 Director
ATRS ANTARES PHARMA, INC. Jul 8, 2021 1 -$429K 4 Jul 9, 2021 Director
ATRS ANTARES PHARMA, INC. Jun 10, 2021 2 $112K 4 Jun 14, 2021 Director